Portfolio company
Bottneuro
Switzerland · £4.0m raised
Raised
£4.0m
Latest stage
Seed
Rounds recorded
1
Backed by
3 investors
Sectors
About
Bottneuro develops personalized non-invasive brain stimulation headsets for patients with neurological conditions such as Alzheimer's disease to provide home-based therapy.
SourceFunding history · 1
Similar companies
Nuuron
This neurotech company develops a digital neuromodulation therapy delivered through virtual reality headsets to treat patients with Alzheimer's disease.
Cognito Tx
This company develops non-invasive wearable devices using light and sound stimulation to treat patients with Alzheimer's and other neurodegenerative diseases.
Neuraworx
This company develops a wearable neurostimulation device that enhances the brain's waste clearance system to treat neurodegenerative diseases and traumatic brain injuries.
MindAhead
This company develops a digital therapy application for individuals with mild cognitive impairment and dementia to slow cognitive decline.
Attune Neurosciences
This company develops wearable ultrasound neurostimulation devices for patients and government agencies to treat brain disorders and improve cognitive performance.
PlatoScience
This company develops neurostimulation headsets and software for clinicians and patients to manage brain stimulation treatments for mental health and cognitive performance.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
BrainQ
This company develops non-invasive, AI-guided electromagnetic neurorehabilitation devices and cloud-based monitoring platforms for stroke survivors and patients with neurological disorders to support recovery.
